Noninvasive Quantitative Evaluation of Early Atherosclerosis and the Effect of Monatepil, a New Antihypertensive Agent An Interim Report
Motoo Tsushima(National Cerebral and Cardiovascular Center), Teruo Omae(National Cerebral and Cardiovascular Center), Masako Waki(Shizuoka City Hospital), Hideki KOH(Institute for Atherosclerosis Research), Masaaki Suzuki(Institute for Atherosclerosis Research), Shingo Kyotani(National Cerebral and Cardiovascular Center), Yutaka Harano(Institute for Atherosclerosis Research), Y Nishioeda(Institute for Atherosclerosis Research)
Cited by 15
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307
Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition
|American Journal of Clinical Nutrition|1992|285